The Leiden Portfolio Companies

Leiden University Research Spinouts

Leiden University is an internationally oriented, comprehensive University. Its scientific research and teaching inspires and shapes its contribution to society. Leiden University encourages an supports entrepreneurship activities which brings valuable research to the market to the benefit society. 

Groundbreaking human tissue and disease models to revolutionize today’s drug discovery and development.

Groundbreaking human tissue and disease models to revolutionize today’s drug discovery and development.

Providing advanced nanopositioning systems specifically tailored for use in cryogenic research.

Providing advanced nanopositioning systems specifically tailored for use in cryogenic research.

Dispertech provides a user-friendly tabletop system for simultaneous measurement of size and scattering intensity of single nanoparticles at high-resolution.

Dispertech provides a user-friendly tabletop system for simultaneous measurement of size and scattering intensity of single nanoparticles at high-resolution.

ZoBio delivers the right small molecule for your target by combining its expertise in protein science, biophysical and biochemical assays, structural biology and medicinal chemistry.

ZoBio delivers the right small molecule for your target by combining its expertise in protein science, biophysical and biochemical assays, structural biology and medicinal chemistry.

Developing innovative technology for the analysis of exosomes for diagnostics and therapeutics.

Developing innovative technology for the analysis of exosomes for diagnostics and therapeutics.

A biotech company which delivers predictive diagnostic tests to improve the selection of drug treatment for cancer patients.

A biotech company which delivers predictive diagnostic tests to improve the selection of drug treatment for cancer patients.

Develops and produces instrumentation for operando research on the nano scale 

Develops and produces instrumentation for operando research on the nano scale 

Developing a potential disease-modifying therapy for two rare life-threatening neurogenetic lysosomal storage disorders

Developing a potential disease-modifying therapy for two rare life-threatening neurogenetic lysosomal storage disorders

Provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during drug development.

Provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during drug development.

Vitrotem provides a fully automated and user-friendly system for the production of Graphene Liquid Cells (GLC).

Vitrotem provides a fully automated and user-friendly system for the production of Graphene Liquid Cells (GLC).

The Centre for Science and Technology Studies (CWTS) studies scientific research and its connections to technology, innovation, and society.

The Centre for Science and Technology Studies (CWTS) studies scientific research and its connections to technology, innovation, and society.

Independent Archaeological Research Office of the University of Leiden.

Independent Archaeological Research Office of the University of Leiden.

Cantoni is a small molecule metabolomic drug development business focussed on the development of an NNMT inhibitor to treat type 2 diabetes and obesity.

LEH Equity and Seed Investments

LEH actively supports and invests directly in student or research spinouts associated with Leiden University. LEH may hold founder shares in new company, may invest when other forms of investment are not available, may operate as a lead shareholder if required, support an active technical relationship with the University, or operate as a passive shareholder at later stage. Investments and support are customized, flexible and investments range from € 200k to € 1M.

BIMINI Biotech develops innovative therapeutic strategies for major unmet medical needs

BIMINI Biotech develops innovative therapeutic strategies for major unmet medical needs

Developing innovative technology for the analysis of exosomes technology for diagnostics and therapeutics.

Developing innovative technology for the analysis of exosomes technology for diagnostics and therapeutics.

Providing advanced nanopositioning systems specifically tailored to the use in cryogenic research.

Providing advanced nanopositioning systems specifically tailored to the use in cryogenic research.

ZoBio delivers the right small molecule for a target by combining its expertise in protein science, biophysical and biochemical assays, structural biology and medicinal chemistry.

ZoBio delivers the right small molecule for a target by combining its expertise in protein science, biophysical and biochemical assays, structural biology and medicinal chemistry.

A biotech company dedicated to deliver predictive diagnostic tests to improve the selection of drug treatment for cancer patients.

A biotech company dedicated to deliver predictive diagnostic tests to improve the selection of drug treatment for cancer patients.

Provides high-throughput gender screening of eggs in hatcheries to avoid the large scale culling of male chicks, and the unnecessary associated emissions from rearing.

Provides high-throughput gender screening of eggs in hatcheries to avoid the large scale culling of male chicks, and the unnecessary associated emissions from rearing.

Provides a range of next-generation genomics services.

Provides a range of next-generation genomics services.

Doser develops 3D printers with cartridges that that make safe and affordable personalised medicine for the pharmacy.

Whispp is an app developed to convert whispers into your own natural voice without delay or stutter.

Enabling personalised therapeutics

Smart bio-lab technology to improve your smart equipment offering.

Cantoni is a small molecule metabolomic drug development business focussed on the development of an NNMT inhibitor to treat type 2 diabetes and obesity.

The Leiden LEH – UNIIQ Portfolio

LEH is a partner of the UNIIQ fund together with TU Delft, Erasmus MC and Innovation Quarter. UNIIQ provides convertible loans of up to € 350k to startups in West Holland. Focused on the proof-of-concept phase, UNIIQ helps entrepreneurs bring their unique innovations to market and helps bridge the riskiest phase of a technology startup business.

Identifying novel targets for cancer therapies, with a range of cancer specific epitopes.

Identifying novel targets for cancer therapies, with a range of cancer specific epitopes.

Developing innovative technology for the analysis of exosomes for diagnostics and therapeutics.

Developing an anticoagulant reversal agent to restore blood clotting in patients.

Developing innovative technology for the analysis of exosomes for diagnostics and therapeutics.

Developing an anticoagulant reversal agent  to restore blood clotting in patients.

BIMINI Biotech develops innovative therapeutic strategies for major unmet medical needs

CONCORD provides a shock free birth for every baby using physiological based cord clamping.

CONCORD provides a shock free birth for every baby using physiological based cord clamping.

BIMINI Biotech develops innovative therapeutic strategies for major unmet medical needs

Segmental Anti-Bacterial Implant Heating

Segmental Anti-Bacterial Implant Heating

Developing new recombinant fibrin(ogen) products for healthcare.

Developing new recombinant fibrin(ogen) products for healthcare.

ELF Pre-seed

ELF Pre-seed is a subsidiary fund of LEH which gives Leiden based students and entrepreneurs access to small soft loans of € 10k to € 70k to validate their business ideas, as well as and a network of relevant experts, coaches and mentors.

Chiff is the logical next step of logging in to websites.

Chiff is the logical next step of logging in to websites.

Molecular techniques to detect pathogens and predict crop losses

Molecular techniques to detect pathogens and predict crop losses 

Levels Diagnostics is specialized in biomarker discovery, clinical studies and the development of rapid diagnostic tools.

Levels Diagnostics is specialized in biomarker discovery, clinical studies and the development of rapid diagnostic tools.

Whispp is an app developed to convert whispers into your own natural voice without delay or stutter.

Rapidemic develops a modular, rapidly adaptable test able to accurately diagnose individuals with infectious diseases.

Rapidemic develops a modular, rapidly adaptable test able to accurately diagnose individuals with infectious diseases.

Developing a sensor based documentation system for laboratories to avoid human-dependent journaling.

Developing a sensor based documentation system for laboratories to avoid human-dependent journaling.

Landscape AI creates comprehensive, data-driven solutions, focused on humans, for town and real estate planning.

Landscape AI creates comprehensive, data-driven solutions, focused on humans, for town and real estate planning.

The digital receipt, straight to your phone.

The digital receipt, straight to your phone.

A strategic and educational board game full of infections, visuals & humor. Players battle against each other using viruses and bacteria.

A strategic and educational board game full of infections, visuals & humor. Players battle against each other using viruses and bacteria.

Leiden Exits

Companies which started in Leiden, received support, and have grown to successful independent growth businesses in the economy. 

Solubility-enhancing formulations to improve the effectiveness drugs, using the unique benefits of deep eutectic solvents.

Solubility-enhancing formulations to improve the effectiveness drugs, using the unique benefits of deep eutectic solvents.

MyLife Technologies specializes in Ceramic Skin Patches for intradermal vaccine delivery.

MyLife Technologies specializes in Ceramic Skin Patches for intradermal vaccine delivery.

Launched in 2011 as a spinout from Leiden University, Ocello was successfully sold to CrownBio in 2021 and remains in Leiden. Ocello developed new technology for compound testing in cultured tissues combining deep image analysis, including organoids and primary patient tissues.
Launched in 2011 as a spinout from Leiden University, Ocello was successfully sold to CrownBio in 2021 and remains in Leiden. Ocello developed new technology for compound testing in cultured tissues combining deep image analysis, including organoids and primary patient tissues.

Follow